Monosaccharide esters: new tools in biomedicine.
The first report dealing with the use of monosaccharide esters as new tools in biomedicine was published in 1997 (1). This topic was first reviewed in 1998 (2). The major aim of the present report is to briefly evoke the background and present knowledge in this field.
Malaisse
W J
WJ
Laboratory of Experimental Medicine, Brussels Free University, 808 Route de Lennik, B-1070 Brussels, Belgium.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D004952:Esters; D005947:Glucose / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D006539:Heptoses / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D009005:Monosaccharides / Q000494:pharmacology* / Q000627:therapeutic use*; D010766:Phosphorylation / Q000187:drug effects; D014407:Tumor Cells, Cultured / Q000187:drug effects
C115456:2-deoxy-glucose tetraacetate; D000970:Antineoplastic Agents; D004952:Esters; D006539:Heptoses; D007328:Insulin; D009005:Monosaccharides; C413547:mannoheptose; C105128:glucose pentaacetate; D005947:Glucose